Finally, we examined the relationship between the levels of hub genes and prognosis and found that only EGFR and COL1A2 were positively correlated with SLC25A21 and linked to poor clinical outcomes in patients with AML (Figures 5E–H). Here, SLC25A21 is linked to acute myeloid leukemia.